Shanghai First People's Hospital

Shanghai Shi 200080

1 studies enrolling now · 1 studies all time

What they study most

End Stage Kidney Disease

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now